Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Enhanced anti-cancer activity of human dendritic cells sensitized with gamma-irradiation-induced apoptotic colon cancer cells.

Kim SK, Yun CH, Han SH.

Cancer Lett. 2013 Jul 28;335(2):278-88. doi: 10.1016/j.canlet.2013.02.038. Epub 2013 Feb 26.

PMID:
23485725
2.
3.

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.

Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G.

J Immunol. 2005 Jul 15;175(2):820-8. Erratum in: J Immunol. 2005 Nov 1;175(9):6235. Prete, Salvatore [corrected to Prete, Salvatore Pasquale].

4.

Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.

Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.

Immunology. 2006 Aug;118(4):483-96. Erratum in: Immunology. 2006 Sep;119(1):143.

5.

Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.

Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.

Cancer Res. 2002 Apr 15;62(8):2347-52.

6.

Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.

Nair SK, Morse M, Boczkowski D, Cumming RI, Vasovic L, Gilboa E, Lyerly HK.

Ann Surg. 2002 Apr;235(4):540-9.

7.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
8.

A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.

Yoneyama S, Okaji Y, Tsuno NH, Kawai K, Yamashita H, Tsuchiya T, Yamada J, Sunami E, Osada T, Kitayama J, Takahashi K, Nagawa H.

Eur J Surg Oncol. 2007 Dec;33(10):1191-8. Epub 2007 Feb 20.

PMID:
17314028
9.

Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.

Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.

Cell Immunol. 2009;257(1-2):23-31. doi: 10.1016/j.cellimm.2009.02.002.

PMID:
19306994
10.

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.

Yasuda T, Kamigaki T, Kawasaki K, Nakamura T, Yamamoto M, Kanemitsu K, Takase S, Kuroda D, Kim Y, Ajiki T, Kuroda Y.

Cancer Immunol Immunother. 2007 Jul;56(7):1025-36. Epub 2006 Nov 28.

PMID:
17131118
11.

Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.

Baxevanis CN, Voutsas IF, Tsitsilonis OE, Gritzapis AD, Sotiriadou R, Papamichail M.

J Immunol. 2000 Apr 1;164(7):3902-12.

12.

Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.

Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, Robbins PD, Watkins SC, Todo S, Herberman RB, Lotze MT, Shurin MR.

J Exp Ther Oncol. 2002 Nov-Dec;2(6):337-49.

PMID:
12440225
13.

Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells.

Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, Bres SA, Laban S, Toes RE, Toebes M, Schumacher TN, Bladergroen BA, Ossendorp F, Kummer JA, Melief CJ, Offringa R.

J Exp Med. 2001 Sep 3;194(5):657-67.

14.

Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.

Yang W, Feng J, Chang X, Fu T, Ye X, Zhang H, Li X, Wen H, Feng L, Tong C, Cui H.

Gynecol Oncol. 2007 Apr;105(1):238-43.

PMID:
17383546
15.

Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.

Hinkel A, Tso CL, Gitlitz BJ, Neagos N, Schmid I, Paik SH, deKernion J, Figlin R, Belldegrun A.

J Immunother. 2000 Jan;23(1):83-93.

PMID:
10687141
16.
17.

Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.

Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.

J Immunol. 2001 Feb 1;166(3):1590-600.

18.

Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.

Hwang EC, Lim MS, Im CM, Kwon DD, Lee HJ, Nguyen-Pham TN, Lee YK, Lee JJ.

Scand J Immunol. 2013 Feb;77(2):117-24. doi: 10.1111/sji.12007.

19.

In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.

Loskog A, Tötterman TH, Böhle A, Brandau S.

Cancer Gene Ther. 2002 Oct;9(10):846-53.

20.

Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.

Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.

Arthritis Rheum. 2005 Jan;52(1):201-11.

Supplemental Content

Support Center